Hong Kong – 23 October 2026 – Sisram Medical Ltd (SISRAM MED) disclosed a repurchase of 100,000 ordinary shares on the Hong Kong Stock Exchange, according to its latest Next Day Disclosure Return filed on 23 October 2026.

The on-market transaction was completed on 23 October 2026 at prices ranging between HKD 1.81 and HKD 1.875 per share, translating into a volume-weighted average purchase price of HKD 1.85072. Total cash consideration amounted to HKD 0.19 million.

Following the buyback, Sisram Medical’s issued share capital (excluding treasury shares) fell by 0.021% to 467.64 million shares. Concurrently, the company’s treasury-share balance rose from 598,400 to 698,400 shares, while the total issued share count (including treasury shares) remained unchanged at 468.34 million.

The purchase was executed under the general mandate approved by shareholders on 24 June 2026, which authorises repurchases of up to 46.83 million shares. Cumulative buybacks under this mandate now stand at 698,400 shares, equivalent to 0.15% of the authorised limit.

In line with Hong Kong listing regulations, Sisram Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 22 November 2026.